GlassScriptPhysician profile
Kyle P Shepperson
NPI 1407831704
$17,605.91
in general payments reported to CMS, 2019-2025
10 companies · $3,828 in 2025
The $3,828 reported for 2025 was more than what 80% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,385 · 2020: $634 · 2021: $3,466 · 2022: $1,837 · 2023: $1,808 · 2024: $3,648 · 2025: $3,828.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,610 · Food and Beverage: $3,650 · Gift: $23.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,609.56 |
| Food and Beverage | $3,650.42 |
| Gift | $23.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,179.29 | 2019-2025 | Blueprint Patient Specific Instrumentation, Triathlon, Aequalis Perform Reversed |
| Medacta USA, INC. | $3,868.04 | 2022-2025 | Amistem, Gmk Sphere, Moto Uni |
| Shoulder Innovations, INC. | $3,033.26 | 2020-2025 | Inset System |
| Elite Orthopedics, LLC | $2,312.65 | 2021-2024 | |
| Conformis, INC. | $2,179.68 | 2020-2023 | Actera Hip Stem |
| Smith+Nephew, INC. | $1,041.36 | 2019-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Arthrex, INC. | $448.48 | 2023 | |
| Restor3d, INC. | $252.34 | 2024-2025 | |
| Acumed LLC | $167.97 | 2024-2025 | Innate Implant, Acumed |
| Zimmer Biomet Holdings, INC. | $122.84 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Shepperson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.